A patient is treated with a specific pharmacological inhibitor that binds reversibly to the active site of a target enzyme, preventing substrate bind…

This describes competitive inhibition. A competitive inhibitor binds reversibly to the active site, competing with the substrate. Because high substrate concentrations can overcome the inhibition, $V_{max}$ remains unchanged. However, more substrate is required to reach half-maximal velocity, resulting in an increased apparent $K_m$.